Switch to:
More From Other Websites
Ligand Announces Third Quarter 2016 Earnings Release Date and Participation in the Stephens Fall... Oct 13 2016
Ligand Partner Lundbeck Receives FDA Approval of Carnexiv™ (carbamazepine) Injection as... Oct 07 2016
Amgen's Multiple Myeloma Drug Kyprolis Fails in Phase III Sep 28 2016
Amgen's Multiple Myeloma Drug Bumbles Key Test Vs. Blockbuster Velcade Sep 27 2016
Ligand Pharmaceuticals, Inc. – Value Analysis (NASDAQ:LGND) : September 27, 2016 Sep 27 2016
Kite Pharma Reports Favorable Data from Lymphoma Study Sep 27 2016
Regeneron, Sanofi Skin Disease Drug Under Priority Review Sep 26 2016
Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps Sep 26 2016
Ligand Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : LGND-US :... Sep 26 2016
Ligand Inks CNS License Agreement with Seelos Therapeutics Sep 23 2016
Teva Reports Positive Phase III Tardive Dyskinesia Data Sep 23 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 22 2016
Ligand Licenses Four Programs to Seelos Therapeutics Sep 22 2016
Ligand (LGND) Inks Deal with TeneoBio for OmniAb Technology Sep 19 2016
ETF’s with exposure to Ligand Pharmaceuticals, Inc. : September 19, 2016 Sep 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)